Ch3 Biosystem LLC entered the industry of Commercial Biotechnical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 5413300, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact John Aletta, Manager by calling (716) 881-8948 during business hours. You can also write to the business’ Single Location at 701 Ellicott St, Buffalo, New York NY 14203. You can also visit the company’s website at ch3biosystems.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Ch3 Biosystem LLC |
Representative: | John Aletta, Manager |
Place of Business: | 701 Ellicott St, Buffalo, NY 14203 |
Contact Number: | (716) 881-8948 |
Website: | ch3biosystems.com |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 5413300 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Ch3 Biosystem LLC is a company operating from Erie, New York providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 5413300 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Ch3 Biosystem LLC has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative John Aletta, Manager at (716) 881-8948 for related queries, or to locate its Single Location using the coordinates 42.89766,-78.86804.
The Single Location can also be found at the street address 701 Ellicott St in Buffalo, New York 14203 and can be engaged online through the company website at ch3biosystems.com, the company Twitter , and Facebook page .